Natco Pharma Limited has informed the Exchange about Copy of Newspaper Publication of Annual Audited Financial Results for the quarter and year ended March 31, 2026
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Natco Pharma Limited has submitted newspaper publications of its audited financial results for Q4 and full year ended March 31, 2026, as required under SEBI Listing Regulations. The results were published on May 30, 2026 in Business Line and Nava Telangana newspapers. The company filed this pursuant to Regulation 47 of the SEBI (LODR) Regulations, 2015. The actual financial figures are not included in this filing document, though the full results are available on the company's website and stock exchange portals.
This is a routine regulatory compliance filing confirming publication of FY2026 annual results. The actual financial performance details would be needed to assess impact on the stock. Investors should refer to the detailed results filing or the newspaper publications for specific numbers on revenue, profits, and other key metrics.